FDA Inspection 1031040 — Honso Pharmaceutical Co Ltd
The FDA completed an inspection of Honso Pharmaceutical Co Ltd on August 29, 2017 in Nagoya. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 29, 2017
- Fiscal Year
- 2017
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Nagoya (Japan)